Search | Page 6 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. What is Secondary MDS? Everything You Need to Know

    ... Treatment-related MDS, also known as secondary MDS , makes up a small fraction of cases of MDS. It is ...

    LMS Item last updated 06/10/2016 - 1:24pm.

  2. Prevalence, clinical characteristics and prognosis of GATA2-related myelodysplastic syndromes (MDS) in children and adolescents

    ... and adolescents with primary myelodysplastic syndrome (MDS) and 82 cases with secondary MDS enrolled in two consecutive prospective studies of the ...

    Research Article last updated 04/29/2016 - 10:24am.

  3. Genetically Modified T-cell Immunotherapy in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

    ... myelodysplastic syndromes (MDS) Associated Drug(s):  ... CD123+ acute myeloid leukemia (AML) de novo , or secondary Relapsed AML is defined as patients that had a first ...

    Clinical Trial last updated 07/14/2016 - 4:08pm.

  4. Risk of developing MDS and AML after radiation treatment for breast cancer

    ... to access the full report. Abstract # 6560 Secondary or t-MDS It is important to recognize that, while secondary MDS (t-MDS) ...

    Research Review last updated 05/02/2016 - 9:32am.

  5. Myelofibrosis (MF)

    ... vera or essential thrombocytosis. This is called secondary myelofibrosis. Patients with MDS, leukemia or even lymphoma can also have fibrosis in their bone ...

    Topic section last updated 07/07/2016 - 3:16pm.

  6. CD34+ Stem Cell Selection for Patients Receiving Allogeneic Stem Cell Transplantation for Non-Malignant Disease

    ... versus host disease, to evaluate incidence of primary and secondary graft rejection, to assess event free survival and overall survival, ... myelodysplastic syndromes (MDS) Gender:  ...

    Clinical Trial last updated 06/13/2016 - 2:06pm.

  7. Donor Stem Cell Transplant in Treating Patients With High Risk Acute Myeloid Leukemia

    ... myelodysplastic syndromes (MDS) Phase:  ... or high risk mutations by FISH eg MLL, FLT-3 + Secondary AML, or A white blood cell count of > 50 x10^9/L ...

    Clinical Trial last updated 06/13/2016 - 3:31pm.

  8. AML Therapy With Irradiated Allogeneic Cells

    ... myelodysplastic syndromes (MDS) Associated Drug(s):  ... =< 1.5 mg/dl Any organ dysfunction thought to be secondary to disease will be considered separately and the patient will be ...

    Clinical Trial last updated 06/13/2016 - 3:14pm.

  9. Phase I/II MEK162 Relapsed and/or Refractory Acute Myeloid Leukemia (AML) and Poor Prognosis, Not Suitable for or Unwilling to Receive Standard Therapy

    ... to patients with relapsed and/or refractory AML, MDS, or ALL. Status:  ... PHASE I -- a. Primary or secondary AML according to WHO classification, with relapsed or refractory ...

    Clinical Trial last updated 06/06/2016 - 10:59am.

  10. Cord Blood Fucosylation to Enhance Homing and Engraftment in Patients With Hematologic Malignancies

    ... myelodysplastic syndromes (MDS) Associated Drug(s):  ... of minimal residual disease by flow cytometry ), secondary leukemia from prior chemotherapy and/or arising from MDS, ...

    Clinical Trial last updated 06/06/2016 - 12:58pm.